Eliem Therapeutics, Inc.
(NASDAQ GM: ELYM)
Rigrodsky Law, P.A. is investigating Eliem Therapeutics, Inc. (“Eliem”) regarding possible breaches of fiduciary duties and other violations of law related to Eliem’s agreement to merge with Tenet Medicines, Inc.